-
-
-
-
-
-
-
Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025
-
-
-
-
-
-
-
Fresenius Medical Care (FMS) Misses Q4 EPS by 26c; offers outlook
-
-
-
-
-
-
-
Fresenius Medical Care starts the year with strong earnings growth
-
-
-
-
-
-
-
Dozens of stocks on watch after Novo Nordisk raises guidance on weight loss drug strength
-
-
-
-
-
-
-
Akebia Announces Second Quarter 2017 Financial Results
-
-
-
-
-
-
-
NxStage Reports Second Quarter Financial Results And Raises Full-Year Revenue Guidance
-
-
-
-
-
-
-
Nomura Securities Starts Fresenius Medical Care (FMS) at Buy
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

